The Food and Drug Administration urged drug makers yesterday to put new warning labels on popular antidepressant medications, including Paxil, Zoloft, and Luvox. The agency’s chief of neurological drugs Dr. Russell Katz said of the advisory “It warns physicians that patients depression may become worse [and] that they may develop suicidal thinking or behavior after the initiation of treatment.”